A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...

New computational modeling of avian influenza variants' immunoprotein interactions—developed by a research team at the ...

Successful high-affinity B cells can proliferate under special conditions that reduce the risk of mutation. Capturing this ...

The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...

New computational modeling of avian influenza variants’ immunoprotein interactions – developed by a research team at the University of North Carolina at Charlotte – reveals the H5N1 influenza virus is ...

New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without ...